Position in RPRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$246,708
-$3,767,805 QoQ
Shares Held
4,400
-94.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#485
of 646 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VESTOR CAPITAL, LLC holds $261,212,724 across 7 Biotechnology names. RPRX ranks #3 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
700,914 | $260,508,706 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
44,835 | $392,530 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
4,400 | $246,708 | |
| 4 | TWST |
Twist Bioscience Corp
|
413 | $42,489 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
285 | $15,657 | |
| 6 | REPL |
Replimune Group, Inc.
|
557 | $6,165 | |
| 7 | JUNS |
Jupiter Neurosciences, Inc.
|
29 | $469 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,708 | 4,400 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,014,513 | 83,688 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $3,280 | 12,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,896,981 | 82,114 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $94 | 5,636 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,599,431 | 404,736 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||